1-Year Follow up to the 1473-IMIQ Study

Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head

NCT01611480 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence

NCT00129519 ·Status: COMPLETED ·Phase: PHASE3

Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream

NCT00189306 ·Status: COMPLETED ·Phase: PHASE3

Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.

NCT06973473 ·Status: NOT_YET_RECRUITING

Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia

NCT06840470 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva

NCT00504023 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma

NCT00189241 ·Status: COMPLETED ·Phase: PHASE3

Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts

NCT00189293 ·Status: COMPLETED ·Phase: PHASE4

Imiquimod for Preventing Keloid Recurrence

NCT03760250 ·Status: TERMINATED ·Phase: PHASE2

Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts

NCT00674739 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Five Treatments in Patients With Plantar Warts

NCT01059110 ·Status: TERMINATED ·Phase: PHASE4

A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts

NCT03278028 ·Status: COMPLETED ·Phase: PHASE2

Study of A-101 Topical Solution for the Treatment of Common Warts

NCT03687372 ·Status: COMPLETED ·Phase: PHASE3

Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts

NCT00735462 ·Status: COMPLETED ·Phase: PHASE3

Topical Imiquimod Treatment of Oral Dysplasia

NCT07210775 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers

NCT03071679 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma

NCT02301494 ·Status: WITHDRAWN ·Phase: NA

Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer

NCT00066872 ·Status: COMPLETED ·Phase: PHASE3

A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453

NCT02052687 ·Status: COMPLETED ·Phase: PHASE1

Study With a Topical Gel to Treat Common Warts in Adults

NCT00117871 ·Status: COMPLETED ·Phase: PHASE2

A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base

NCT00463359 ·Status: UNKNOWN ·Phase: NA

A Double-blind, Randomized, Single Centre, Vehicle-controlled Study to Evaluate the Safety and Tolerability of a New Topical Formulation Containing 0,09% Imiquimod (Limtop) in Healthy Subjects

NCT01567683 ·Status: COMPLETED ·Phase: PHASE1

Comparing Immune Responses to Topical Imiquimod

NCT04809662 ·Status: TERMINATED

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

NCT00314756 ·Status: COMPLETED ·Phase: PHASE4

Study With a Topical Gel to Treat Common Warts in Adults

NCT00117923 ·Status: COMPLETED ·Phase: PHASE2